171 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
) a decrease of $0.1 million in personnel costs due to headcount reductions; partially offset by (iv) the reversal of $0.5 million in incentive bonus
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
of $0.2 million in incentive bonus expense; and (iv) a decrease of $0.1 million in insurance costs; partially offset by (v) an increase of $0.4
8-K
WINT
Windtree Therapeutics Inc
28 Aug 23
Departure of Directors or Certain Officers
4:15pm
bonus of 30% of her base salary.
There are no arrangements or understandings between Ms. McAndrew and any other persons pursuant to which Ms. McAndrew
8-K
EX-99.1
ydoc06uom2 95bnd6nbl
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm
8-K
EX-1.1
alrxy7qc8
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B4
ls1ps2vm8u58
20 Apr 23
Prospectus supplement with pricing info
6:03pm
S-8
EX-99.1
j36avr
18 May 22
Registration of securities for employees
4:12pm